GMED 分类 A Globus Medical, Inc. Class A Common Stock
NYSE · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$75.60
· % 处于52周区间
· 高于低点
· 至高点
$56.5052周低点
$101.4052周高点
P/E (TTM)
19.4
EPS (TTM)
$3.89
收入 (TTM)
$3.14B
GMED 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$75.60
P/E (TTM)
19.4
EPS (TTM)
$3.89
收入 (TTM)
$3.14B
ROE (TTM)
11.8%
52周区间
$57–$101
GMED 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Globus Medical, Inc. Class A Common Stock 公司概况（来自维基百科）
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
行业板块Health Care
行业Health Care
员工6000
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$2.94B2016-12-31 → 2025-12-31
EPS$3.922016-12-31 → 2025-12-31
自由现金流$589M2016-12-31 → 2025-12-31
净利率17.0%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | GMED | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 19.45年均值 ≈54.5 | ≈54.5 | 28.6 | 低估 | |
| PEG Ratio (市盈率增长比) | ≈0.6 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | GMED | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 20.3%5年均值 ≈12.3% | ≈12.3% | 13.1% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | 29.2%5年均值 ≈21.3% | ≈21.3% | 13.7% | 顶尖 | |
| 税前利润率 (TTM) | 21.0%5年均值 ≈13.7% | ≈13.7% | 11.8% | 顶尖 | |
| 净利润率 (TTM) | 17.0%5年均值 ≈11.4% | ≈11.4% | 9.0% | 顶尖 | |
| ROA (TTM) | 10.2%5年均值 ≈6.0% | ≈6.0% | 4.6% | 顶尖 | |
| ROE (TTM) | 11.8%5年均值 ≈6.6% | ≈6.6% | 8.9% | 顶尖 | |
| ROIC | 9.3%5年均值 ≈5.8% | ≈5.8% | 7.1% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | GMED | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 4.65年均值 ≈4.5 | ≈4.5 | 2.4 | 流动性强 | |
| 速动比率 (MRQ) | 2.75年均值 ≈1.9 | ≈1.9 | 1.0 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | GMED | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 16.7%5年均值 ≈31.8% | ≈31.8% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 42.2%5年均值 ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 30.1% | · | · | · | |
| EPS YoY | 422.7%5年均值 ≈84.3% | ≈84.3% | · | · | |
| Net Income YoY (净利润同比增长) | 422.3%5年均值 ≈88.8% | ≈88.8% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | 28.4%5年均值 ≈3.6% | ≈3.6% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | 31.2% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | 41.4%5年均值 ≈12.0% | ≈12.0% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | 39.4% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | GMED | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.65年均值 ≈0.5 | ≈0.5 | 0.5 | 持平 | |
| Inventory Turnover (库存周转率) | 1.45年均值 ≈1.2 | ≈1.2 | 1.8 | 弱 | |
| Receivables Turnover (应收账款周转率) | 4.85年均值 ≈5.0 | ≈5.0 | 6.2 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$489.8K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
16.2%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 5, 2026 | $1.34 | $1.12 | 19.5% |
| 2026年3月31日 | 五月 12, 2026 | $1.12 | $0.94 | 19.4% |
| 2025年12月31日 | $1.28 | $1.17 | 9.2% | |
| 2025年9月30日 | $1.18 | $0.80 | 47.8% | |
| 2025年6月30日 | $0.86 | $0.77 | 11.6% | |
| 2025年3月31日 | $0.68 | $0.76 | -10.4% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $14.05 | $12.03 | $10.01 | $8.67 | $7.50 | $6.18 | |
| Revenue / Share | $21.44 | $18.27 | $13.68 | · | $9.25 | $7.81 | $7.70 | $7.04 | $6.50 | $5.85 | $5.67 | $4.97 | |
| Cash Flow / Share | $5.50 | $3.78 | $2.12 | · | $2.67 | $1.97 | $1.69 | $1.79 | $1.63 | $1.78 | $1.27 | $0.83 | |
| Cash / Share | · | · | · | · | · | · | $1.96 | $1.42 | $1.23 | $1.38 | $0.63 | $0.87 | |
| EPS (TTM) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | · | 134,502,000 | 135,205,000 | 136,757,000 | · | 135,615,000 | 135,195,000 | 135,358,000 | · | 113,537,000 | 100,373,000 | 100,279,000 | · | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | · | 135,394,000 | 136,499,000 | 139,774,000 | · | 138,062,000 | 136,979,000 | 135,358,000 | · | 115,245,000 | 101,782,000 | 102,196,000 | · | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.75 | $5.50 | · | $5.68 | $5.46 | $4.28 | · | $4.53 | $4.60 | $4.48 | · | $3.33 | $2.87 | $2.71 | · | $2.51 | |
| Cash Flow / Share | · | $1.46 | · | · | · | $1.27 | · | · | · | $0.39 | · | · | · | $0.52 | · | · | |
| EPS (TTM) | $3.89 | $4.28 | · | $3.10 | $2.60 | $1.34 | · | $0.57 | $0.20 | $0.54 | · | $1.54 | $2.00 | $1.96 | · | $1.52 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.14B | $3.10B | · | $2.77B | $2.63B | $2.51B | · | $2.48B | $2.24B | $1.90B | · | $1.23B | $1.10B | $1.07B | · | $998M | |
| Net Income TTM | $535M | $587M | · | $424M | $357M | $186M | · | $92M | $41M | $67M | · | $158M | $204M | $201M | · | $155M | |
| P/E | 20.3 | 20.1 | · | 18.5 | 22.7 | 54.6 | · | 125.5 | 342.4 | 99.3 | · | 32.2 | 29.8 | 28.9 | · | 39.2 | |
| Earnings Yield | 4.9% | 5.0% | · | 5.4% | 4.4% | 1.8% | · | 0.80% | 0.29% | 1.0% | · | 3.1% | 3.4% | 3.5% | · | 2.5% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| 毛利率 % | · | · | 65.0% | · | 75.0% |
| 营业利润率 % | 16.3% | 6.6% | 8.5% | · | 17.9% |
| 净收入 | $538M | $103M | $123M | $190M | $149M |
| 稀释后每股收益 (EPS) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 4.3 | 2.5 | 4.9 | · | 6.2 |
| 速动比率 | 2.5 | 0.8 | 1.4 | · | 3.0 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $589M | $405M | $165M | · | $219M |
机构持有人 (13F) 639 家申报者 · $10.4B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
639
持有价值
$10.4B
新仓位
76
已退出持仓
82
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 76 (-42 与上一季度对比) | 82 (+32 与上一季度对比) | 254 (+26 与上一季度对比) | 180 (0 与上一季度对比) | +5.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $921072916 | 10549455 | 8.82% | 股份 |
| BlackRock, Inc. | $853839261 | 10806724 | 8.18% | 股份 |
| JANUS HENDERSON GROUP PLC | $656831032 | 7623095 | 6.29% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $403546103 | 5107532 | 3.86% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394606359 | 4994385 | 3.78% | 股份 |
| Invesco Ltd. | $340515006 | 4309771 | 3.26% | 股份 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $338141467 | 4279730 | 3.24% | 股份 |
| STATE STREET CORP | $293540630 | 3714029 | 2.81% | 股份 |
| Sculptor Capital LP | $237030000 | 3000000 | 2.27% | 股份 |
| JPMORGAN CHASE & CO | $230761440 | 2743850 | 2.21% | 股份 |
| Burgundy Asset Management Ltd. | $212054428 | 3460983 | 2.03% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $205090439 | 2380344 | 1.96% | 股份 |
| BANK OF MONTREAL /CAN/ | $191638042 | 2425491 | 1.83% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $187250224 | 2369310 | 1.79% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $170151584 | 2153014 | 1.63% | 股份 |
| GOLDMAN SACHS GROUP INC | $140764853 | 1781608 | 1.35% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135630225 | 1716621 | 1.30% | 股份 |
| Boston Trust Walden Corp | $124311253 | 1573361 | 1.19% | 股份 |
| Boston Partners | $122847510 | 1554990 | 1.18% | 股份 |
| Allspring Global Investments Holdings, LLC | $119384889 | 1571681 | 1.14% | 股份 |
| GENEVA CAPITAL MANAGEMENT LLC | $111962440 | 1417067 | 1.07% | 股份 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101519633 | 1284896 | 0.97% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $98471901 | 1246322 | 0.94% | 股份 |
| Quantinno Capital Management LP | $96320933 | 1219098 | 0.92% | 股份 |
| NORGES BANK | $89048300 | 1127051 | 0.85% | 股份 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88055393 | 1114484 | 0.84% | 股份 |
| MORGAN STANLEY | $86496544 | 1094753 | 0.83% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84736329 | 1072476 | 0.81% | 股份 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $81207111 | 1027808 | 0.78% | 股份 |
| WELLS FARGO & COMPANY/MN | $78742680 | 996617 | 0.75% | 股份 |
| Madison Avenue Partners, LP | $73891416 | 935216 | 0.71% | 股份 |
| ANTIPODES PARTNERS Ltd | $71581796 | 905984 | 0.69% | 股份 |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $70042286 | 886499 | 0.67% | 股份 |
| NORTHERN TRUST CORP | $69578813 | 880633 | 0.67% | 股份 |
| AXA Investment Managers S.A. | $68885959 | 1202828 | 0.66% | 股份 |
| Global Alpha Capital Management Ltd. | $67681230 | 856616 | 0.65% | 股份 |
| Vestal Point Capital, LP | $67158500 | 850000 | 0.64% | 股份 |
| UBS Group AG | $65909432 | 834191 | 0.63% | 股份 |
| Bank of New York Mellon Corp | $61258598 | 775328 | 0.59% | 股份 |
| FMR LLC | $60683705 | 768051 | 0.58% | 股份 |
| BANK OF AMERICA CORP /DE/ | $58239298 | 737113 | 0.56% | 股份 |
| Stephens Investment Management Group LLC | $57159864 | 723451 | 0.55% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $56575822 | 716059 | 0.54% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $54970813 | 695745 | 0.53% | 股份 |
| Clark Capital Management Group, Inc. | $54271890 | 686899 | 0.52% | 股份 |
| AMERICAN CAPITAL MANAGEMENT INC | $51599219 | 653072 | 0.49% | 股份 |
| ANCHOR CAPITAL ADVISORS LLC | $51225201 | 648338 | 0.49% | 股份 |
| Camber Capital Management LP | $47216000 | 800000 | 0.45% | 股份 |
| Capital World Investors | $46664254 | 590612 | 0.45% | 股份 |
| Artemis Investment Management LLP | $45305914 | 573420 | 0.43% | 股份 |
公司内部人士 22 位内幕人士 · 11 位高管 · 15 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | 2026年1月21日 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | 2025年1月23日 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | 2022年1月27日 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | 2026年1月21日 A | 0 | 0 | 2 | $-2032133 |
| Richard A Baron | Senior VP and CFO | 2014年5月2日 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | 2019年3月7日 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | 2026年2月25日 M | 0 | 0 | 3 | $-3441700 |
| David C Paul | Executive Chairman | 2026年1月21日 A | 60417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | 2019年2月1日 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | 2018年6月25日 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | 2018年2月2日 A | 35217 | 0 | 0 | $0 |
| James R Tobin | 董事 | 2026年9月15日 M | 0 | 0 | 1 | $-2237400 |
| Stephen T Zarrilli | 董事 | 2026年8月18日 M | 0 | 0 | 2 | $-4283250 |
| David D Davidar | 董事 | 2026年7月27日 G | 507675 | 0 | 2 | $-4169000 |
| Ann D Rhoads | 董事 | 2026年6月4日 M | 40384 | 0 | 2 | $-818000 |
| Dan Wolterman | 董事 | 2026年1月21日 A | 24025 | 0 | 0 | $0 |
| Leslie V Norwalk | 董事 | 2026年1月21日 A | 10419 | 0 | 2 | $-557600 |
| Dan Lemaitre | 董事 | 2026年1月21日 A | 0 | 0 | 0 | $0 |
| John A Deford | 董事 | 2026年1月21日 A | 15578 | 0 | 0 | $0 |
| Robert Andrew Douglas | 董事 | 2026年1月21日 A | 2005 | 0 | 0 | $0 |
| Kurt Wheeler | 董事 | 2019年1月22日 A | 44319 | 0 | 0 | $0 |
| Robert Liptak | 董事 | 2019年1月22日 A | 26159 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 69 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2.90% | 16797 NS | 2026年7月31日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 2.26% | 300351 NS | 2026年7月31日 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1.83% | 122008 SH | 2026年10月2日 | 每日 |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.52% | 13339 NS | 2026年7月31日 | N-PORT |
| BUL · Pacer Funds Trust | 1.37% | 22796 NS | 2026年7月31日 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1.35% | 340460 NS | 2026年7月31日 | N-PORT |
| IHI · iShares Trust | 1.25% | 541723 SH | 2026年9月11日 | 每日 |
| RFG · Invesco Exchange-Traded Fund Trust | 0.81% | 36501 SH | 2026年10月2日 | 每日 |
| MCOW · Pacer Funds Trust | 0.68% | 92 NS | 2026年7月31日 | N-PORT |
| SMDX · Tidal Trust III | 0.58% | 9542 NS | 2026年7月31日 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0.50% | 13493 SH | 2026年10月2日 | 每日 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.47% | 111810 SH | 2026年8月19日 | 每日 |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.34% | 20104 NS | 2026年7月31日 | N-PORT |
| FNY · First Trust Exchange-Traded Alpha... | 0.32% | 23234 NS | 2026年7月31日 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trus... | 0.30% | 16476 SH | 2026年10月2日 | 每日 |
| JPUS · J.P. Morgan Exchange-Traded Fund ... | 0.29% | 16839 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.28% | 35968 SH | 2026年9月11日 | 每日 |
| BKMC · BNY Mellon ETF Trust | 0.27% | 22533 NS | 2026年7月31日 | N-PORT |
| PTMC · Pacer Funds Trust | 0.25% | 12456 NS | 2026年7月31日 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.25% | 183180 SH | 2026年8月19日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | 0.24% | 1499816 SH | 2026年8月19日 | 每日 |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.19% | 49674 NS | 2026年7月31日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.19% | 1664 NS | 2026年7月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 57770 NS | 2026年7月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.15% | 284148 NS | 2026年7月31日 | N-PORT |
| IYH · iShares Trust | 0.13% | 65761 SH | 2026年9月11日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.13% | 338547 SH | 2026年8月19日 | 每日 |
| RWK · Invesco Exchange-Traded Fund Trus... | 0.13% | 22085 SH | 2026年10月2日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 53700 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.13% | 245718 NS | 2026年7月31日 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0.12% | 39173 NS | 2026年7月31日 | N-PORT |
| SMMD · iShares Trust | 0.11% | 59918 SH | 2026年9月11日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.11% | 2596850 SH | 2026年8月19日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.10% | 1300059 SH | 2026年8月19日 | 每日 |
| VFMF · VANGUARD WELLINGTON FUND | 0.10% | 8946 SH | 2026年8月19日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.10% | 103731 NS | 2026年7月31日 | N-PORT |
| INFO · Harbor ETF Trust | 0.10% | 10513 NS | 2026年7月31日 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.10% | 10277 SH | 2026年10月2日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.10% | 6977 NS | 2026年7月31日 | N-PORT |
| IWS · iShares Trust | 0.08% | 166482 SH | 2026年9月11日 | 每日 |
| WSML · iShares Trust | 0.08% | 6832 SH | 2026年9月11日 | 每日 |
| FNX · First Trust Exchange-Traded Alpha... | 0.07% | 13036 NS | 2026年7月31日 | N-PORT |
| IWR · iShares Trust | 0.06% | 458676 SH | 2026年9月11日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.04% | 87854 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.04% | 2717 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.03% | 205429 NS | 2026年7月31日 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Inde... | 0.03% | 20026 SH | 2026年10月2日 | 每日 |
| DFSU · Dimensional ETF Trust | 0.03% | 8925 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.03% | 11916 NS | 2026年7月31日 | N-PORT |
| IUSG · iShares Trust | 0.02% | 99439 SH | 2026年9月11日 | 每日 |
| IWD · iShares Trust | 0.02% | 248750 SH | 2026年9月11日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 67710 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.02% | 25284 SH | 2026年8月19日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.02% | 27167 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 38185 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 3476 NS | 2026年7月31日 | N-PORT |
| IYY · iShares Trust | 0.01% | 4949 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.01% | 77825 SH | 2026年9月11日 | 每日 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.01% | 15270 SH | 2026年10月2日 | 每日 |
| ITOT · iShares Trust | 0.01% | 145193 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.01% | 30738 SH | 2026年9月11日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 3596212 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 89702 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 18804 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9508 SH | 2026年8月19日 | 每日 |
| IJH · iShares Trust | · | 3976473 SH | 2026年9月11日 | 每日 |
| IJK · iShares Trust | · | 657157 SH | 2026年9月11日 | 每日 |
| XJH · iShares Trust | · | 15479 SH | 2026年9月8日 | 每日 |
| ISCB · iShares Trust | · | 5094 SH | 2026年9月11日 | 每日 |
GMED 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 23 位分析师
买入
中位数目标
$100.00
+32.3%
4 17.4%
强烈买入
12 52.2%
买入
7 30.4%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
13 位分析师 · 2026-10-03平均目标 $100.92 +33.5%
← 低于所有目标
当前价格 $75.60
最低$84.00
平均值$100.92
最高$125.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
BLUECHIP_DIP
止损出局
风险 1
奖励 1.71
入场
$80.54
R:R 1.71
BLUECHIP_DIP
止损出局
风险 1
奖励 1.92
入场
$79.89
R:R 1.92
BLUECHIP_DIP
止损出局
风险 1
奖励 1.79
入场
$82.29
R:R 1.79
目前没有公开信号 — 没有卡片被填写，这是诚实的。
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报